|
|
||
Re: Hmm, almost $4 and I see nothing in the newsJanson/JNJ has decided to move forward with MDS trial. Accelerated Phase 2/3 design that will start enrolling this year. That GERN is still trading under $4 is a minor miracle. Look for it to move steadily higher into ASH meeting and beyond. -bin |
return to message board, top of board |